Eco R1 Capital, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $1.27 Billion distributed in 46 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apellis Pharmaceuticals, Inc. with a value of $260M, Jazz Pharmaceuticals PLC with a value of $212M, Crinetics Pharmaceuticals, Inc. with a value of $144M, Prothena Corp Public LTD CO with a value of $143M, and Sarepta Therapeutics, Inc. with a value of $82.5M.

Examining the 13F form we can see an decrease of $868M in the current position value, from $2.14B to 1.27B.

Eco R1 Capital, LLC is based out at San Francisco, CA

Below you can find more details about Eco R1 Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.27 Billion
Healthcare: $1.27 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 46
  • Current Value $1.27 Billion
  • Prior Value $2.14 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 5 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.